Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX
Lexicon Pharmaceuticals (LXRX) Ownership Overview
22.92% Insiders
7.24% Mutual Funds
0.02% Other Institutional Investors
2.61% ETFs
67.21% Public Companies and
Individual Investors
The ownership structure of Lexicon Pharmaceuticals (LXRX) stock is a mix of institutional, retail, and individual investors. Approximately 9.87% of the company’s stock is owned by Institutional Investors, 22.92% is owned by Insiders, and 67.21% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 27, 2026 | xxxxxxxxxxxxx | $2980 | |
Feb 25, 2026 | xxxxxxxxxxxxx | $147000 | |
Feb 23, 2026 | xxxxxxxxxxxxx | $218500 | |
Feb 18, 2026 | xxxxxxxxxxxxx | $351720 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $38660 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $126385 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 51,660,909 | Insider | 12.19% | 90,406,591 | |
| 42,606,727 | Insider | 10.06% | 74,561,772 | |
| 19,159,424 | Institution | 4.52% | 33,528,992 | |
| 9,375,812 | Institution | 2.21% | 16,407,671 | |
| 7,674,213 | Institution | 1.81% | 13,429,873 | |
| 1,934,942 | Institution | 0.46% | 3,386,149 | |
| 1,162,005 | Institution | 0.27% | 2,033,509 | |
| 552,779 | Institution | 0.13% | 967,363 | |
| 515,300 | Institution | 0.12% | 901,775 | |
| 512,672 | Institution | 0.12% | 897,176 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 19,159,424 | Institution | 4.52% | 33,528,992 | |
| 7,674,213 | Institution | 1.81% | 13,429,873 | |
| 1,934,942 | Institution | 0.46% | 3,386,149 | |
| 552,779 | Institution | 0.13% | 967,363 | |
| 515,300 | Institution | 0.12% | 901,775 | |
| 280,725 | Institution | 0.07% | 491,269 | |
| 181,299 | Institution | 0.04% | 317,273 | |
| 122,411 | Institution | 0.03% | 214,219 | |
| 90,000 | Institution | 0.02% | 157,500 | |
| 75,792 | Institution | 0.02% | 132,636 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,847,451 | Institution | 1.62% | 10,065,753 | |
| 1,979,562 | Institution | 0.47% | 2,909,956 | |
| 1,054,168 | Institution | 0.25% | 1,802,627 | |
| 548,799 | Institution | 0.13% | 806,735 | |
| 464,440 | Institution | 0.11% | 812,770 | |
| 109,434 | Institution | 0.03% | 187,132 | |
| 48,232 | Institution | 0.01% | 84,406 | |
| 13,200 | Institution | <0.01% | 28,908 | |
| 9,658 | Institution | <0.01% | 16,902 |
FAQ
Who Owns Lexicon Pharmaceuticals (LXRX)?
According to the latest TipRanks data, approximately 0.02% of the company's stock is held by institutional investors, 22.92% is held by insiders, and 67.21% is held by retail investors.
What percentage of Lexicon Pharmaceuticals (LXRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.02% of Lexicon Pharmaceuticals (LXRX) stock is held by institutional investors.
What percentage of Lexicon Pharmaceuticals (LXRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 67.21% of Lexicon Pharmaceuticals (LXRX) stock is held by retail investors.
Who owns the most shares of Lexicon Pharmaceuticals (LXRX)?
Raymond Debbane owns the most shares of Lexicon Pharmaceuticals (LXRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.